4.8 Letter

Plasma Neutralization of the SARS-CoV-2 Omicron Variant

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 386, 期 6, 页码 599-601

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2119641

关键词

-

资金

  1. National Institutes of Health [R37AI64003, R01AI501111, R01AI78788, P01-AI138398-S1, 2U19AI111825]
  2. National Center for Advancing Translational Sciences (National Institutes of Health Clinical and Translational Science Award program) [UL1 TR001866]
  3. Shapiro-Silverberg Fund for the Advancement of Translational Research

向作者/读者索取更多资源

Neutralization assays showed much lower omicron neutralization compared to Wuhan-hu-1 after two doses of mRNA vaccine, but individuals who received a booster vaccine or were vaccinated after recovering from Covid-19 exhibited high levels of omicron neutralization.
Omicron Neutralization after the Third Vaccine Dose Neutralization assays of SARS-CoV-2 pseudoviruses expressing wild-type, omicron, or a synthetic resistant spike protein in plasma drawn from 47 people over time showed much lower omicron neutralization than Wuhan-hu-1 neutralization after two doses of an mRNA vaccine. However, samples from persons vaccinated after recovery from Covid-19 and those who received a booster vaccine had high levels of omicron neutralization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据